Through this investment, the Sligo site will feature Class 7 cleanroom manufacturing environments and state-of-the art thermoforming operations, fully certified to ISO 13485 standards and meeting the highest regulatory requirements.
The Swedish electric vehicle battery manufacturer says it will construct a major new production facility in the city of Heide near Germany’s North Sea coastline.
Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, has announced completion of additions to its research capacity and services
It is a milestone on the path to the chip factory of the future: at the new Bosch semiconductor fab in Dresden, silicon wafers are passing through the fully automated fabrication process for the first time. This is a key step toward the start of production operations, which is scheduled for late 2021. Manufacturing of automotive microchips will be a primary focus when the fully digital and highly connected semiconductor plant is up and running. “Chips for tomorrow’s mobility solutions and greater safety on our roads will soon be produced in Dresden. We plan to open our chip factory of the future before the year is out,” says Harald Kroeger, member of the board of management of Robert Bosch GmbH. The company already operates a semiconductor fab in Reutlingen near Stuttgart. The new wafer fab in Dresden is Bosch’s response to the surging number of areas of application for semiconductors, as well as a renewed demonstration of its commitment to Germany as a high-tech location. Bosch is investing around one billion euros in the high-tech manufacturing facility, which will be one of the most advanced wafer fabs in the world. Funding for the new building is being provided by the federal German government, and more specifically the Federal Ministry for Economic Affairs and Energy. Bosch plans to officially open its wafer fab in June 2021.
MTI Instruments’ Accumeasure HD System Proven to Be Highest Resolution Capacitance System in the World. The results were recently published in a white paper by Kevin Harding of Optical Metrology Solutions. Harding’s white paper can be accessed on MTI Instruments’ website. Harding’s independent study confirmed the findings of an internal experiment by MTI Instruments that concluded the Accumeasure HD system can provide picometer-level accuracy when used with 50-micron HD capacitive probes.
Viant announced today that it has completed a major expansion of its medical device manufacturing facility in Heredia, Costa Rica. The company invested in the additional capacity to meet market demand for minimally invasive surgical devices, including energy-based devices. The expansion will benefit customers by enhancing Viant’s ability to provide speed to market for high-quality, complex medical devices.
ColdQuanta, the leader in Cold Atom Quantum Technology, has been awarded two development contracts from U.S. Government agencies worth $2.55M in total. Both projects are based on the company’s Quantum Core™ technology that uses atoms cooled to a temperature of nearly absolute zero, and lasers to manipulate and control the atoms with extreme precision.
QuickFreeze® (by Tippmann Engineering) made in the U.S.A., is equipment driving innovation in the cold chain. The latest innovation, QFM, was issued its first patent, patent #10,921,043. The QFM, released in 2019, allows cold storage providers and food production facilities to freeze (temper, chill, etc…) palletized products faster than ever before.
Modesto, California, manufacturer Enviro Tech Chemical Services (ETCS) has introduced ReducX, its newest cleaning and disinfecting formula for food and beverage equipment and facility cleaning.
Based on its recent analysis of the global medical gloves market, Frost & Sullivan recognizes Smart Glove Holdings with the 2020 Global Medical Gloves Technology Innovation Leadership Award.
Bright semiconductor nanocrystals known as quantum dots give QLED TV screens their vibrant colors. But attempts to increase the intensity of that light generate heat instead, reducing the dots’ light-producing efficiency.
Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, ceremonially broke ground today on its new 25,000 ft2 facility which will house its GMP virus production suites, development laboratories and company offices. The new building will be located in Providence Park at 2501 Earl Rudder Freeway in College Station.